Hepatic impairment
Showing 1 - 25 of >10,000
Non-alcoholic Steatohepatitis, Hepatic Impairment Trial (Efinopegdutide)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- Hepatic Impairment
- (no location specified)
Sep 18, 2023
Hepatic Impairment, Healthy Trial in Saint Paul, San Antonio (Obicetrapib)
Not yet recruiting
- Hepatic Impairment
- Healthy
-
Saint Paul, Minnesota
- +1 more
Sep 21, 2023
Hepatic Impairment Trial in Hialeah (Avacopan)
Completed
- Hepatic Impairment
-
Hialeah, FloridaClinical Pharmacology of Miami, Inc.
Aug 15, 2023
Hepatic Impairment, Pharmacokinetics Trial in Jilin (ZSP1273)
Not yet recruiting
- Hepatic Impairment
- Pharmacokinetics
-
Jilin, ChinaThe First Hospital of Jilin University
May 4, 2023
Hepatic Impairment Trial (Elacestrant diHCl)
Not yet recruiting
- Hepatic Impairment
- Elacestrant dihydrochloride
- (no location specified)
Nov 6, 2023
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Renal Impairment, Hepatic Impairment Trial in Jinan (SIM0417 600 mg; Ritonavir100 mg, SIM0417 375 mg; Ritonavir100 mg, SIM0417
Not yet recruiting
- Renal Impairment
- Hepatic Impairment
- SIM0417 600 mg; Ritonavir100 mg
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Feb 7, 2023
Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis Trial in Orlando, San Antonio, Kistarcsa (TVB-2640 - 50 mg)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- +2 more
- TVB-2640 - 50 mg
-
Orlando, Florida
- +2 more
Apr 17, 2023
Hepatic Impairment Trial in Szikszo (Part 1; LOU064 (Remibrutinib), Part 2; LOU064 (Remibrutinib))
Recruiting
- Hepatic Impairment
- Part 1; LOU064 (Remibrutinib)
- Part 2; LOU064 (Remibrutinib)
-
Szikszo, HungaryNovartis Investigative Site
Feb 22, 2023
Hepatic Function Abnormal Trial (Fexinidazole (HOE239))
Not yet recruiting
- Hepatic Function Abnormal
- Fexinidazole (HOE239)
- (no location specified)
Jan 10, 2023